A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of signed informed consent form
Males and female of non-child bearing potential patients aged 18 to 80 years
Patients with neuropathic pain due to painful diabetic polyneuropathy.
You may not be if
Other pain that may confound assessment of neuropathic pain
History of treatment failure with more than three adequate trials of medication for neuropathic pain
Central neuropathic pain conditions (caused by Central Nervous System injury/disease, eg. Stroke)
Clareo Health | A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
